Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US

被引：0
|
作者：
Sundar Jagannath
Nedra Joseph
Jinghua He
Concetta Crivera
Alex Z. Fu
Ashraf Garret
Nina Shah
机构：
[1] Icahn School of Medicine at Mount Sinai,Real World Value and Evidence (Oncology)
[2] Janssen Scientific Affairs,undefined
[3] LLC,undefined
[4] Janssen Scientific Affairs,undefined
[5] LLC,undefined
[6] Georgetown University Medical Center,undefined
[7] Legend Biotech Inc.,undefined
[8] University of California San Francisco,undefined
来源：
Oncology and Therapy | 2021年 / 9卷
关键词：
Healthcare costs; Healthcare resource utilization; Multiple myeloma; Triple class exposure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：659 / 669
页数：10
相关论文
共 50 条
  • [21] Real-World Costs, Health Care Resource Utilization (HCRU), and Outcomes Among Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) in the US
    Nair, S.
    Lin, X.
    Potluri, R.
    Slavcev, M.
    Marshall, A.
    VALUE IN HEALTH, 2022, 25 (12) : S152 - S152
  • [22] HEALTHCARE RESOURCE UTILIZATION AND COSTS OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA
    Bhowmik, D.
    Hines, D. M.
    Intorcia, M.
    McGuiness, C. B.
    Wade, R. L.
    VALUE IN HEALTH, 2017, 20 (05) : A103 - A103
  • [23] A LONGITUDINAL RETROSPECTIVE CLAIMS ANALYSIS OF HEALTHCARE COSTS INCURRED BY UTERINE FIBROIDS PATIENTS
    Soliman, A. M.
    Fuldeore, M.
    Yang, H.
    Du, E. X.
    Wu, E. Q.
    Winkel, C.
    FERTILITY AND STERILITY, 2014, 102 (03) : E284 - E285
  • [24] CHARACTERIZING EXPOSURE-RESPONSE RELATIONSHIPS OF IDECABTAGENE VICLEUCEL IN PATIENTS WITH TRIPLE-CLASS-EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Zhou, J.
    Burnett, J.
    Zheng, X.
    Chen, Y.
    Caia, A.
    Cook, M.
    Kondic, A.
    Lamba, M.
    Wu, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S82 - S82
  • [25] Treatment Patterns and Healthcare Resource Utilization Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study
    Visram, Alissa
    Seow, Hsien
    Pond, Gregory
    Gayowsky, Ana
    McCurdy, Arleigh
    Cipkar, Christopher
    Sapru, Hyra
    Kouroukis, C. Tom
    Aljama, Mohammed
    Ebraheem, Mohammad
    Foley, Stephen Ronan
    Mian, Hira
    BLOOD, 2023, 142
  • [26] Healthcare Resource Utilization and Costs Associated with Different Treatment Modalities of Relapsed/Refractory Multiple Myeloma Patients in the US: Findings from Preamble
    Kuter, David J.
    Chen, Clara
    Popov, Sergey
    Davis, Catherine
    Vij, Ravi
    BLOOD, 2017, 130
  • [27] Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma
    Atieh, Tahani
    Atrash, Shebli
    Ahmed, Nausheen
    Mohan, Meera
    Cui, Wei
    Shune, Leyla
    Hajjar, Susana
    Mahmoudjafari, Zahra
    Quick, Julie
    Wishna, Anne
    Riffel, Justin
    McGuirk, Joseph
    Mohyuddin, Ghulam Rehman
    Abdallah, Al-Ola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (12): : 912 - 919
  • [28] Outcomes of Triple Class Refractory Multiple Myeloma Patients: A Single Center Retrospective Study
    Danis, Ryan
    Yashar, David
    Bujarski, Sean
    Jew, Scott
    Swift, Regina
    Berenson, James R.
    BLOOD, 2023, 142
  • [29] Healthcare Costs Associated with Osteoarthritis in US Patients
    Le, T. Kim
    Montejano, Leslie B.
    Cao, Zhun
    Zhao, Yang
    Ang, Dennis
    PAIN PRACTICE, 2012, 12 (08) : 633 - 640
  • [30] Healthcare Costs of Secondhand Smoke Exposure at Home for US Children
    Yao, Tingting
    Sung, Hai-Yen
    Wang, Yingning
    Lightwood, James
    Max, Wendy
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2019, 56 (02) : 281 - 287
12345